Rate My Professor Anne Avery

Anne Avery is a Professor of Immunology in the Department of Microbiology, Immunology, and Pathology at Colorado State University’s College of Veterinary Medicine and Biomedical Sciences, where she also serves as Director of the Clinical Hematopathology Laboratory and Associate Department Head for DVM and Clinical Service. She earned a B.A. from Mount Holyoke College in 1982, a V.M.D. from the University of Pennsylvania in 1990, and a Ph.D. in Immunology from Cornell University in 1991. After veterinary school, Avery completed a small animal internship at the University of Pennsylvania and practiced relief and emergency veterinary medicine for ten years. She conducted postdoctoral research at the Dana-Farber Cancer Institute on T cell function and development, followed by a fellowship at Colorado State University studying malaria immunology, joining the faculty there in 1994. In 2001, she established the Clinical Hematopathology Laboratory, which in 2023 processed samples from over 20,000 unique canine and feline patients across more than 4,000 clinics nationwide, providing diagnostic flow cytometry, PARR assays, Ki67 proliferation analysis, and immunohistochemical services.

Avery’s research focuses on the immunological mechanisms driving development of lymphoma and leukemia in dogs and cats, investigating molecular and functional features of acute leukemia, peripheral T-cell lymphoma, T-zone lymphoma in dogs, and intestinal T-cell lymphoma in cats. Her work emphasizes comparative oncology, identifying parallels between veterinary and human hematologic malignancies. Key publications include “Flow Cytometric Characterization and Clinical Outcome of CD4+ T-cell Lymphoma in Dogs: 67 Cases” (Avery et al., Journal of Veterinary Internal Medicine, 2014), “Canine T-Zone Lymphoma: Unique Immunophenotypic Features, Outcome, and Population Characteristics” (Seelig et al., Journal of Veterinary Internal Medicine, 2014), “Polyclonal B-cell Lymphocytosis in English Bulldogs” (Rout et al., Journal of Veterinary Internal Medicine, 2020), and “Using Digital RNA Counting to Establish Flow Cytometry Diagnostic Criteria for Subtypes of CD34+ Canine Acute Leukemia” (Harris et al., Veterinary and Comparative Oncology, 2022). Through diagnostic innovation and research leveraging vast clinical samples, Avery has advanced veterinary hematopathology, improving prognostics and therapies for companion animals with potential translational benefits to human medicine.